Jean Jacques Fournie
Cancer Research Center of Toulouse,France
Biography
Jean Jacques Fournié completed his PhD (Biochemistry and Immunology) from Toulouse University and a Post-doctoral stay at the Clinical Immunology Research Center of University of Sydney, Australia. He is the Founding Director of Cancer Research Center of Toulouse, an international cancer research laboratory from INSERM, University of Toulouse 3 and CNRS, and leads the research team ‘Innovating Therapeutics Strategies in Lymphomas’ of Laboratoire d’Excellence Toulouse Cancer at Institut Universitaire du Cancer of Toulouse-Oncopole, France. He published more than 150 papers in reputed journals, produced 21 patents and co-founded the Innate Pharma Company (www.innate-pharma.com).
Abstract
Abstract : Stratifying patients for Immune checkpoint blockade cancer therapies
